QNCX Projected Dividend Yield
Quince Therapeutics Inc ( NASDAQ : QNCX )Quince Therapeutics is a clinical stage biopharmaceutical company focused on therapeutic approaches to improve the lives of patients diagnosed with Alzheimer's and degenerative diseases. Co.'s portfolio of gingipain inhibitors are orally administered, brain-penetrating small molecules. Co.'s pipeline includes proprietary drug candidates for the treatment of CNS disorders including Alzheimer's disease, for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of conditions like periodontitis. Co.'s pipeline also includes proprietary irreversible protease inhibitors under development for the treatment of coronavirus infection. 20 YEAR PERFORMANCE RESULTS |
QNCX Dividend History Detail QNCX Dividend News QNCX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |